Real Vision Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Real Vision Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors…

2011-12-30 Bhubaneswar, Orissa Active Unlisted Active Compliant
Share
RV Real Vision Pharmaceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Real Vision Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
65/100
Trust Score
Moderate

Real Vision Pharmaceuticals Private Limited is assessed as Moderate with a Trust Score of 65/100. Real Vision Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Trading sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Real Vision Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
65/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
15/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.

Charges position: 1 open (10.25 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Idbi Bank Limited1 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
SUBHASISH SAHOO 01234567 Director 01/04/2018 6 yrs Approved
DEBASISH MISHRA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • SUBHASISH SAHOO has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2016)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Operating for 14+ years.
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment44/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 10.25 Lakh already registered.
  • Compliance record supports lending.
Investor view22/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
07 Aug 2015
Charge created
Idbi Bank Limited - 10.25 Lakh
07 Aug 2014
Director ceased
DEVI PRASAD MOHANTY
Director ceased
BISWARANJAN TUNGA
Director ceased
TUSAR PATTANAIK
Director ceased
KUMAR SATYAJIT SAHU
06 Aug 2014
Director appointed
DEBASISH MISHRA (Director)
16 Jan 2013
Director appointed
SUBHASISH SAHOO (Director)
Director ceased
JANMEJAYA MOHANTY
16 Aug 2012
Director ceased
SUDHIR KUMAR BEHERA
30 Dec 2011
Incorporated
Registered with Roc Cuttack
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Pratibha Corporation Private Limited U74999MH2014PTC255917 Nagpur, Maharashtra, India
Kolkata Electro Trade Private Limited U31901WB2007PTC114614 Kolkata, West Bengal, India
Mithratheja Project Private Limited U41001KA2014PTC074651 Bangalore, Karnataka, India
Sunview Syntex Private Limited U17100RJ2009PTC059427 Bhilwara, Rajasthan, India
Tanaria Apparel Private Limited U51909PN2013PTC147356 Pune, Maharashtra, India
Avid Trading Private Limited U51909MH2008PTC178608 Goregaon East, Maharashtra, India
Lytyfy U74130CT2014PTC001515 Raipur, Chattisgarh, India
Blastoff Web Solutions Private Limited U72900DL2009PTC188390 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Real Vision Pharmaceuticals Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Real Vision Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Real Vision Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 65/100, distress signals and MSME payment-delay disclosures - know whether Real Vision Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Real Vision Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Real Vision Pharmaceuticals Private Limited an active company?

Real Vision Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Real Vision Pharmaceuticals Private Limited financially healthy?

Real Vision Pharmaceuticals Private Limited has a Financial Health Score of 15/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Real Vision Pharmaceuticals Private Limited?

Its overall Trust Score is 65/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Real Vision Pharmaceuticals Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Real Vision Pharmaceuticals Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Real Vision Pharmaceuticals Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Real Vision Pharmaceuticals Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.